Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for fibronectin receptors (compound)
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Human umbilical vein endothelial cells (HUVECs) adhering to soluble VEGFR1 or fibronectin
Most Relevant Literature
- Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoin…
- Co-localization of Fibronectin Receptors LILRB4/gp49B and Integrin on Dendritic Cell Surface.
- Fibronectin and Its Receptors in Hematopoiesis.
- Expression and significance of integrin α5β1 and fibronectin in atherosclerotic plaques from autopsy…
- Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that faci…
Most Relevant Clinical Trials
- Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
- Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
- A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Adva…
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanc…
